LEADER 04826oas 2201105 a 450 001 9910333112803321 005 20241231213015.0 011 $a2212-1102 035 $a(DE-599)ZDB2677520-7 035 $a(OCoLC)802230270 035 $a(CONSER) 2012250782 035 $a(CKB)3460000000023844 035 $a(EXLCZ)993460000000023844 100 $a20120726a20129999 uy 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aValue in health regional issues 210 $aNew York, N.Y. $cElsevier Inc.$dİ2012- 215 $a1 online resource 300 $aRefereed/Peer-reviewed 311 08$a2212-1099 330 $aValue in Health Regional Issues (ViHRI) is a new scientific journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) to encourage and enhance the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions in Asia, Latin America, Central & Eastern Europe, Western Asia, and Africa. Value in Health Regional Issues, a peer-reviewed publication, is an independent journal (unique ISSN), and is related to Value in Health only in cover design and contents. The scope and mission of Value in Health Regional Issues is consistent with the mission and scope of the Society. Value in Health Regional Issues includes articles on health care policy analysis, outcomes research (clinical, economic, and patient-reported) empirical studies, methodological studies, and articles on health care resources in the region. Health care decision-maker commentaries that stimulate communication between health outcomes researchers and policymakers are welcome. Commentaries are expected to include discussion on how researchers can better respond to the needs of those making clinical and financial decisions in health care. 517 1 $aViHRI 606 $aMedical technology$xEvaluation$vPeriodicals 606 $aRegional planning$xEvaluation$vPeriodicals 606 $aMedical care$xEvaluation$vPeriodicals 606 $aPharmaceutical technology$xEvaluation$vPeriodicals 606 $aBiotechnology$xEvaluation$vPeriodicals 606 $aOutcome Assessment, Health Care 606 $aEconomics, Pharmaceutical 606 $aTechnology, Medical$xstandards 606 $aHealth Resources$xstandards 606 $aRisk Assessment 606 $aMedical care$xEvaluation$2fast$3(OCoLC)fst01013794 606 $aMedical technology$xEvaluation$2fast$3(OCoLC)fst01014750 606 $aRegional planning$xEvaluation$2fast$3(OCoLC)fst01093145 606 $aE?valuation du risque 606 $aE?valuation des re?sultats (Soins me?dicaux) 606 $aPharmacoe?conomie 606 $aAme?nagement du territoire$xE?valuation$vPe?riodiques 606 $aTechnologie me?dicale$xE?valuation$vPe?riodiques 606 $aSoins me?dicaux$xE?valuation$vPe?riodiques 606 $aTechniques pharmaceutiques$xE?valuation$vPe?riodiques 606 $aBiotechnologie$xE?valuation$vPe?riodiques 606 $arisk assessment$2aat 608 $aPeriodical 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 615 0$aMedical technology$xEvaluation 615 0$aRegional planning$xEvaluation 615 0$aMedical care$xEvaluation 615 0$aPharmaceutical technology$xEvaluation 615 0$aBiotechnology$xEvaluation 615 12$aOutcome Assessment, Health Care. 615 22$aEconomics, Pharmaceutical 615 22$aTechnology, Medical$xstandards 615 22$aHealth Resources$xstandards 615 22$aRisk Assessment 615 7$aMedical care$xEvaluation. 615 7$aMedical technology$xEvaluation. 615 7$aRegional planning$xEvaluation. 615 6$aE?valuation du risque. 615 6$aE?valuation des re?sultats (Soins me?dicaux) 615 6$aPharmacoe?conomie. 615 6$aAme?nagement du territoire$xE?valuation 615 6$aTechnologie me?dicale$xE?valuation 615 6$aSoins me?dicaux$xE?valuation 615 6$aTechniques pharmaceutiques$xE?valuation 615 6$aBiotechnologie$xE?valuation 615 7$arisk assessment. 712 02$aInternational Society for Pharmacoeconomics and Outcomes Research. 801 0$bAU@ 801 1$bAU@ 801 2$bOCLCO 801 2$bTXA 801 2$bBUF 801 2$bTEF 801 2$bCUS 801 2$bOCLCQ 801 2$bFIE 801 2$bOCLCQ 801 2$bUAB 801 2$bOCLCQ 801 2$bOCLCF 801 2$bOCLCQ 801 2$bOCLCO 801 2$bOCLCA 801 2$bOCLCL 906 $aJOURNAL 912 $a9910333112803321 996 $aValue in health regional issues$91892726 997 $aUNINA